About this trial
The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving alcohol use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
Eligibility criteria
Qualifiers
Age>=18 years;
History of bipolar I disorder, bipolar II disorder, or schizoaffective disorder of the bipolar type. Can be clinical diagnosis
Ability to read, write, and understand English;
Minimum DAST (1+) or AUDIT-C score (3+)
Disqualifiers
Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment;
Needing a higher level of mental health care as demonstrated by ASAM[36] assessment; - completed by LADC or MD investigators
Already admitted into or about to initiate treatment in another addiction treatment program.
Currently attending High School. (can be 18 though)
Trial design
Treatments tested in this trial
- Senyo Health App